DB2 PIOGLITAZONE MONOTHERAPY IS ASSOCIATED WITH A SIGNIFICANTLY LOWER INCIDENCE OF CARDIOVASCULAR EVENTS THAN IS INSULIN THERAPY IN PATIENTS WITH TYPE 2 DIABETES- A RETROSPECTIVE PROPENSITY-ADJUSTED COHORT ANALYSIS
Nov 1, 2003, 00:00
10.1016/S1098-3015(10)61560-4
https://www.valueinhealthjournal.com/article/S1098-3015(10)61560-4/fulltext
Title :
DB2 PIOGLITAZONE MONOTHERAPY IS ASSOCIATED WITH A SIGNIFICANTLY LOWER INCIDENCE OF CARDIOVASCULAR EVENTS THAN IS INSULIN THERAPY IN PATIENTS WITH TYPE 2 DIABETES- A RETROSPECTIVE PROPENSITY-ADJUSTED COHORT ANALYSIS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)61560-4&doi=10.1016/S1098-3015(10)61560-4
First page :
Section Title :
Open access? :
No
Section Order :
6